Allscripts (MDRX) Tops Q2 EPS by 6c

Allscripts (NASDAQ: MDRX) reported Q2 EPS of $0.23, $0.06 better than the analyst estimate of $0.17. Revenue for the quarter came in at $374 million versus the consensus estimate of $373.45 million.

For earnings history and earnings-related data on Allscripts (MDRX) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Pulmatrix (PULM) Reports Q2 Loss of $0.29
• Live Ventures (LIVE) Reports Q3 Loss of $0.34